Posted by : Irvin Jackson
Consumers paid premium prices for cold medications for decades which contained a nasal decongestant that did not work, the lawsuit claims.
Following a determination made last week by a panel of scientific advisors to the U.S. government, which found that the decongestant phenylephrine is no more effective than a placebo, a Minnesota woman has filed a class action lawsuit against the makers of Sudafed.
The complaint (PDF) was brought by Miesha McIntyre in the U.S. District Court for the District of Minnesota on September 15, seeking class-action status to pursue damages on behalf of all consumers from the drug maker Kenvue, Inc. and McNeil Consumer Healthcare as defendants.
Both companies were previously owned by Johnson & Johnson, and comprised its over-the-counter consumer medication division. They have since been spun off into Kenvue, which is now a separate company that owns McNeil.
Sudafed Decongestant Does Not Work
Earlier this month, an advisory committee to the U.S. Food and Drug Administration (FDA) determined that the decongestant phenylephrine is ineffective when taken orally. Even though its been on the market for decades in popular products like Sudafed, Mucinex and Tylenol Cold and Flu tablets and liquids, recent data indicates it is no more effective than a placebo.
The FDA must now decide whether it should be allowed to remain on the market.
The post Sudafed Class Action Lawsuit Filed Over “Ineffective” Decongestant in Cold Medications appeared first on AboutLawsuits.com.
- November 2023 Roundup Litigation Report
- Progress in Talcum Powder Lawsuits – November 2023 Update
- Ozempic Weight Loss Drug Faces Legal Battle
- Feds Say Camp Lejeune Water Cases Can’t Go To Trial
- Camp Lejeune
- Client Acquistion
- Client Financing
- Company Business
- Daily Dose of Law
- Digital Display Advertising
- Google Maps Ranking
- Human Trafficking
- Law Firm Info
- Lead Generation
- Litigation Funding
- Mass Tort News
- Mass Tort Signed Cases
- Personal Injury Leads
- Sex Abuse Cases